Managed Care


Statin Spending Up 156 Percent

MANAGED CARE July 2008. © MediMedia USA
News and Commentary

Statin Spending Up 156 Percent

MANAGED CARE July 2008. ©MediMedia USA

Spending on statins increased 156 percent between 2000 and 2005, according to “Trends in Statins Utilization and Expenditures for the U.S. Civilian Noninstitutionalized Population, 2000 and 2005,” issued by the Agency for Healthcare Research and Quality.

In 2000, outpatient prescription expenditures for statins amounted to $7.7 billion. That rose to $19.7 billion in 2005. Statins include drugs such as atorvastatin (Lipitor), fluvastatin (Lescol), pravastatin (Pravachol), and simvastatin (Zocor).

Further, the average annual personal expenditure for statins increased about 37 percent ($484 and $661, respectively) during that time period. The number of prescriptions purchased for statins nearly doubled from 2000 to 2005, rising from 89.7 million to 173.7 million. The number of persons purchasing a statin increased 88 percent from 2000 to 2005, rising from 15.8 million to 29.7.


2014 Annual HEDIS® and Star Ratings Symposium Nashville, TN November 3–4, 2014
PCMH & Shared Savings ACO Leadership Summit Nashville, TN November 3–4, 2014
Medicare Risk Adjustment, Revenue Management, & Star Ratings Fort Lauderdale, FL November 12–14, 2014
World Orphan Drug Congress Europe 2014 Brussels, Belgium November 12–14, 2014
Healthcare Chief Medical Officer Forum Alexandria, VA November 13–14, 2014
Home Care Leadership Summit Atlanta, GA November 17–18, 2014
6th Semi-Annual Diagnostic Coverage and Reimbursement Conference Boston December 4–5, 2014
Customer Analytics & Engagement in Health Insurance Chicago December 4–5, 2014
Pharmaceutical and Biotech Clinical Quality Assurance Conference Alexandria, VA December 4–5, 2014
9th Semi-Annual Medical Device Coverage and Reimbursement Conference San Diego December 5, 2014
8th Annual Medical Device Clinical Trials Conference Chicago December 8–9, 2014
HealthIMPACT Southeast Tampa, FL January 23, 2015